We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Diabetes

Journal Scan / Research · May 20, 2021

Short-Term Intensive Insulin as Induction and Maintenance Therapy for the Preservation of Beta-Cell Function in Early T2D

Diabetes, Obesity & Metabolism

 

Additional Info

Diabetes, Obesity & Metabolism
Short-Term Intensive Insulin as Induction and Maintenance Therapy for the Preservation of Beta-Cell Function in Early Type 2 Diabetes (RESET IT): A 2-Year Randomized Controlled Trial
Diabetes Obes Metab 2021 May 06;[EPub Ahead of Print], R Retnakaran, A Emery, C Ye, SB Harris, SM Reichert, N McInnes, HC Gerstein, KE Thorpe, CK Kramer, B Zinman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading